#MyPhenome
LightNews LightNews
imcrit.bsky.social
Medical factoid:

A genetic test called MyPhenome can help predict how a person will respond to GLP-1 agonists (semaglutide-tirzepatide)

It classifies patients into one of two phenotypes:
"hungry-gut" (+) and "hungry-gut" (-) (or should I say: "hungry-brain" (+)?)
September 26, 2025 at 1:00 AM
d-and-d-world.bsky.social
Phenomix Sciences unveils new data at #Obesity"/hashtag/ObesityWeek2025" class="hover:underline text-blue-600 dark:text-sky-400 no-card-link">#ObesityWeek2025 showing its #MyPhenome test accurately predicts #GLP1 therapy response and obesity risk across diverse populations.

#News #PrecisionMedicine #ObesityResearch #HealthcareInnovation #Genomics #WeightLoss #Obesity
Phenomix expands evidence for GLP-1 response predicting MyPhenome test
New data show the MyPhenome test accurately predicts GLP-1 response and obesity risk across diverse populations.
druganddeviceworld.com
November 4, 2025 at 7:01 PM
d-and-d-world.bsky.social
Phenomix Sciences has showcased another potential use for its MyPhenome test, this time in identifying patients at high risk of regaining weight following bariatric surgery.

#news #obesity #gasticbypass #bariatricsurgery #weightloss #research
MyPhenome test predicts weight regain after bariatric surgery
Mayo Clinic study finds that MyPhenome test can identify patients at high risk of regaining weight after bariatric surgery.
druganddeviceworld.com
May 29, 2025 at 6:01 PM
d-and-d-world.bsky.social
The prospective placebo-controlled trial will evaluate Phenomix's MyPhenome test’s ability to predict patient response to a GLP-1 obesity therapy, semaglutide.

#news #obesity #weightloss #research
Phenomix trials MyPhenome test to predict response to semaglutide
The prospective placebo-controlled trial will evaluate the MyPhenome test’s ability to predict patient response to a GLP-1 obesity therapy, semaglutide.
druganddeviceworld.com
April 9, 2025 at 2:39 PM
newsen.bsky.social
Phenomix Sciences Introduces MyPhenome: A Precision Obesity Test for Personalized Weight Management#USA#Menlo_Park#Obesity_Treatment#Phenomix_Sciences#MyPhenome
Phenomix Sciences Introduces MyPhenome: A Precision Obesity Test for Personalized Weight Management
Phenomix Sciences has launched MyPhenome, a pioneering genetic obesity test designed to tailor weight loss treatment based on individual biology, enhancing patient outcomes.
third-news.com
June 16, 2026 at 2:34 PM
newsen.bsky.social
New Insights from Mayo Clinic Highlight MyPhenome Test's Role in Weight Loss Predictability#USA#Menlo_Park#Obesity_Treatment#Phenomix_Sciences#MyPhenome_Test
New Insights from Mayo Clinic Highlight MyPhenome Test's Role in Weight Loss Predictability
Recent studies from Mayo Clinic reveal the MyPhenome test's ability to predict weight loss outcomes for various obesity treatments, enhancing personalized medicine.
third-news.com
May 5, 2026 at 2:59 PM
newsen.bsky.social
Phenomix Sciences Advances MyPhenome™ Test for Predicting Obesity and GLP-1 Response in Diverse Populations#United_States#Menlo_Park#GLP-1#Phenomix#MyPhenome
Phenomix Sciences Advances MyPhenome™ Test for Predicting Obesity and GLP-1 Response in Diverse Populations
Phenomix Sciences showcases its MyPhenome test at Obesity Week 2025, revealing its effectiveness in predicting responses to GLP-1 treatments across varied populations.
third-news.com
November 4, 2025 at 2:52 PM
newsen.bsky.social
Phenomix and Mayo Clinic Publish Groundbreaking Study on MyPhenome Test for Personalized Obesity Treatment#USA#Menlo_Park#Mayo_Clinic#Phenomix#MyPhenome
Phenomix and Mayo Clinic Publish Groundbreaking Study on MyPhenome Test for Personalized Obesity Treatment
Phenomix Sciences and Mayo Clinic have published a significant study validating the MyPhenome genetic test, enhancing the personalization of obesity treatments based on individual biology.
third-news.com
June 10, 2025 at 2:45 PM
l2plabs.bsky.social
Phenomix Sciences Launches MyPhenome® Test Directly to Patients to Help Guide Weight Loss Treatment Based on Biology
Now available directly to patients, MyPhenome is the first and only precision obesity test that goes beyond GLP-1 treatment response to help guide treatment decisions across a broad range of obesity therapies and interventions. Phenomix Sciences has launched direct patient access to its...
dlvr.it
June 16, 2026 at 1:05 PM
l2plabs.bsky.social
Phenomix Sciences Expands Evidence for MyPhenome™ Test Predicting GLP-1 Response and Obesity Risk in Large, Diverse Populations
Studies presented at Obesity Week 2025 validate the test's ability to predict weight-loss response to GLP-1 drugs like semaglutide, including in diverse patient populations and post-bariatric surgery patients. Phenomix's MyPhenome test continues to demonstrate predictive accuracy in...
dlvr.it
November 4, 2025 at 2:06 PM
l2plabs.bsky.social
Phenomix and Mayo Clinic Publish Research Demonstrating Utility of MyPhenome Test for Personalized GLP-1 and Phen-Top Treatment
Published in Cell Metabolism, the Phenomix and Mayo Clinic research shows the MyPhenome™ test can help providers guide obesity treatment by matching patients to GLP-1s or phentermine/topiramate based on their unique biology. MENLO PARK, Calif., June 10, 2025 /PRNewswire/ -- Phenomix...
dlvr.it
June 10, 2025 at 1:07 PM
l2plabs.bsky.social
Duly Health Brings Genetic-Based Weight Loss Treatment to Chicago with MyPhenome Test
Chicago-area patients now have access to precision medicine for obesity care with genetic obesity test from Phenomix Sciences. MENLO PARK, Calif., March 13, 2025 /PRNewswire/ -- Phenomix Sciences (Phenomix), a precision medicine biotechnology company that…
dlvr.it
March 13, 2025 at 1:37 PM
phalguniddw.bsky.social
Phenomix Sciences unveils new data at #Obesity"/hashtag/ObesityWeek2025" class="hover:underline text-blue-600 dark:text-sky-400 no-card-link">#ObesityWeek2025 showing its #MyPhenome test accurately predicts #GLP1 therapy response and obesity risk across diverse populations.

#News #PrecisionMedicine #ObesityResearch #HealthcareInnovation #Genomics #WeightLoss #Obesity
Phenomix expands evidence for GLP-1 response predicting MyPhenome test
New data show the MyPhenome test accurately predicts GLP-1 response and obesity risk across diverse populations.
druganddeviceworld.com
November 4, 2025 at 7:01 PM
phalguniddw.bsky.social
Phenomix Sciences has showcased another potential use for its MyPhenome test, this time in identifying patients at high risk of regaining weight following bariatric surgery.

#news #obesity #gasticbypass #bariatricsurgery #weightloss #research
MyPhenome test predicts weight regain after bariatric surgery
Mayo Clinic study finds that MyPhenome test can identify patients at high risk of regaining weight after bariatric surgery.
druganddeviceworld.com
May 29, 2025 at 6:01 PM
phalguniddw.bsky.social
The prospective placebo-controlled trial will evaluate Phenomix's MyPhenome test’s ability to predict patient response to a GLP-1 obesity therapy, semaglutide.

#news #obesity #weightloss #research
Phenomix trials MyPhenome test to predict response to semaglutide
The prospective placebo-controlled trial will evaluate the MyPhenome test’s ability to predict patient response to a GLP-1 obesity therapy, semaglutide.
druganddeviceworld.com
April 9, 2025 at 2:39 PM
drtimos.bsky.social
Thoughts on this? >> Phenomix Sciences Launches Clinical Trial to Predict GLP-1
Response Using Precision Obesity Test >> Comment below! #AI #industry40 #healthtech #mhealth #IoT
Phenomix Sciences Launches Clinical Trial to Predict GLP-1 Response Using Precision Obesity Test
What You Should Know:  – Phenomix Sciences (Phenomix), a commercial precision obesity medicine biotechnology company, today announced the initiation of its first prospective, placebo-controlled clinical study.  – The research will evaluate the MyPhenome™ test’s ability to predict individual patient responses to semaglutide, a GLP-1-based therapy that has become a cornerstone in the treatment of obesity. ... Read More
dlvr.it
April 9, 2025 at 11:04 PM